Motiva Ergonomix Round SilkSurface Silicone Breast Implants: Outcome Analysis of 100 Primary Breast Augmentations over 3 Years and Technical Considerations
- PMID: 29794696
- DOI: 10.1097/PRS.0000000000004367
Motiva Ergonomix Round SilkSurface Silicone Breast Implants: Outcome Analysis of 100 Primary Breast Augmentations over 3 Years and Technical Considerations
Abstract
Background: Macrotextured anatomical implants are frequently used in aesthetic breast surgery; however, several safety concerns linked to this implant type have been raised recently. In an attempt to address these shortcomings, Motiva Ergonomix implants have been introduced. Here, the authors describe the current world's largest experience with these novel devices in aesthetic breast surgery and evaluate the postoperative outcome of 100 primary breast augmentations.
Methods: A retrospective assessment of 100 consecutive primary breast augmentation patients over a period of 3 years was conducted. Patients were followed for a minimum of 6 months postoperatively. Demographics, surgical data, and complications were recorded. In addition, a survey regarding the breast augmentation outcome was performed.
Results: The reasons for surgery were mainly hypoplasia (52 percent) and ptosis (28 percent). All implants were placed by means of an inframammary approach in a submuscular pocket, and the average implant volume was 370 cc (range, 150 to 700 cc) with mostly full projection (65 percent). The revision rate was 7 percent. The authors observed four cases of implant malpositioning, one implant rupture, one implant exchange for aesthetic reasons, and one hematoma evacuation. Nevertheless, the authors achieved a 100 percent satisfaction rate with the postsurgical outcome among both patients and surgeons.
Conclusions: Motiva Ergonomix implants provide reliable and satisfying results for both patients and surgeons. They can be used safely and effectively for aesthetic breast surgery. However, like all breast prostheses, Motiva Ergonomix implants are not completely free of complications and should be used only with advanced technique to achieve optimal results.
Clinical question/level of evidence: Therapeutic, IV.
Comment in
-
Discussion: Motiva Ergonomix Round SilkSurface Silicone Breast Implants: Outcome Analysis of 100 Primary Breast Augmentations over 3 Years and Technical Considerations.Plast Reconstr Surg. 2018 Jun;141(6):843e-844e. doi: 10.1097/PRS.0000000000004420. Plast Reconstr Surg. 2018. PMID: 29794697 No abstract available.
-
Reply: Motiva Ergonomix Round SilkSurface Silicone Breast Implants: The Tale of Goldilocks: Never Be Afraid of Exploring Unknown Territory.Plast Reconstr Surg. 2019 Jan;143(1):240e-241e. doi: 10.1097/PRS.0000000000005147. Plast Reconstr Surg. 2019. PMID: 30418313 No abstract available.
-
The Tale of Goldilocks: The Middle is the Place to Be.Plast Reconstr Surg. 2019 Jan;143(1):239e-240e. doi: 10.1097/PRS.0000000000005146. Plast Reconstr Surg. 2019. PMID: 30418315 No abstract available.
References
-
- Spear SL, Parikh PM, Goldstein JAHistory of breast implants and the Food and Drug Administration. Clin Plast Surg. 2009;36:1521, v.
-
- Carter M, Purpura JAnaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases, and breast implant-associated anaplastic large cell lymphoma. A systematic review. Plast Reconstr Surg. 2015;136:106e.
-
- Billner M, Wirthmann A, Reif S, Rieger UMPoly Implant Prothèse and Rofil substandard breast implant explantations from a large German single centre from 2011 to 2014: A comparative study. Aesthetic Plast Surg. 2016;40:507513.
-
- Clemens MW, Miranda RN, Butler CEBreast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016;137:11171122.
-
- Maxwell GP, Gabriel AThe evolution of breast implants. Clin Plast Surg. 2009;36:113, v.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials